[{"indications": "Indications\u00a0Wilson\u2019s disease (initiated under specialist\r\nsupervision)", "name": "ZINC ACETATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.8 Metabolic disorders", "9.8.1 Drugs used in metabolic disorders", "Wilson\u2019s disease"], "cautions": "Cautions\u00a0portal hypertension (risk of hepatic\r\ndecompensation when switching from chelating agent); monitor full blood count and serum cholesterol; interactions: Appendix 1 (zinc)", "side-effects": "Side-effects\u00a0gastric irritation (usually transient; may be\r\nreduced if first dose taken mid-morning or with a little protein); less commonly sideroblastic anaemia and leucopenia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129095.htm", "doses": ["Dose expressed as\r\nelemental zinc", "Wilson\u2019s disease, 50\u00a0mg 3 times daily (max. 50\u00a0mg 5 times daily),\r\nadjusted according to response; child 1\u20136 years, 25\u00a0mg twice daily; 6\u201316 years, body-weight under 57\u00a0kg,\r\n25\u00a0mg 3 times daily, body-weight over 57\u00a0kg, 50\u00a0mg 3 times daily; adolescent 16\u201318 years, 50\u00a0mg 3 times daily"], "pregnancy": "Pregnancy\u00a0reduce dose to 25\u00a0mg 3 times daily adjusted according\r\nto plasma-copper concentration and urinary copper excretion"}]